Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Clinical trial NCT04421963 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04421963
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2027-04-06
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.